Bristol-Myers Squibb buy UBS Group AG
Start price
07.01.26
/
50%
€47.50
Target price
07.01.27
€55.55
Performance (%)
5.22%
Price
10.04.26
€49.98
Summary
This prediction is currently active. With a performance of 5.22%, the BUY prediction by UBS_Group_AG for Bristol-Myers Squibb is trending in the right direction. This prediction currently runs until 07.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bristol-Myers Squibb | -3.271% | -3.271% |
| iShares Core DAX® | 2,55 % | -0,11 % |
| iShares Nasdaq 100 | 2,74 % | -0,47 % |
| iShares Nikkei 225® | 6,58 % | 3,22 % |
| iShares S&P 500 | 1,93 % | -0,52 % |
Comments by UBS_Group_AG for this prediction
In the thread Bristol-Myers Squibb diskutieren
Bristol Myers Squibb (NYSE:BMY) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $65.00 price target on the stock.
Ratings data for BMY provided by MarketBeat